{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T10:05:45Z","timestamp":1782727545007,"version":"3.54.5"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,2,17]],"date-time":"2012-02-17T00:00:00Z","timestamp":1329436800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Blood Cancer Journal"],"DOI":"10.1038\/bcj.2012.1","type":"journal-article","created":{"date-parts":[[2012,2,17]],"date-time":"2012-02-17T14:30:28Z","timestamp":1329489028000},"page":"e57-e57","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":81,"title":["MicroRNA signatures in B-cell lymphomas"],"prefix":"10.1038","volume":"2","author":[{"given":"L","family":"Di Lisio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"S\u00e1nchez-Beato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"G\u00f3mez-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M E","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Montes-Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Mollejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Men\u00e1rguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M A","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F J","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D G","family":"Pisano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M A","family":"Piris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,2,17]]},"reference":[{"key":"BFbcj20121_CR1","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"SH Swerdlow","year":"2008","unstructured":"Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press: Lyon, 2008."},{"key":"BFbcj20121_CR2","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1080\/10428190903189035","volume":"50","author":"M Aggarwal","year":"2009","unstructured":"Aggarwal M, Sanchez-Beato M, Gomez-Lopez G, Al-Shahrour F, Martinez N, Rodriguez A et al. Functional signatures identified in B-cell non-Hodgkin lymphoma profiles. Leuk Lymphoma 2009; 50: 1699\u20131708.","journal-title":"Leuk Lymphoma"},{"key":"BFbcj20121_CR3","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1056\/NEJMoa055351","volume":"354","author":"M Hummel","year":"2006","unstructured":"Hummel M, Bentink S, Berger H, Klapper W, Wessendorf S, Barth TF et al. A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. N Engl J Med 2006; 354: 2419\u20132430.","journal-title":"N Engl J Med"},{"key":"BFbcj20121_CR4","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1056\/NEJMoa055759","volume":"354","author":"SS Dave","year":"2006","unstructured":"Dave SS, Fu K, Wright GW, Lam LT, Kluin P, Boerma EJ et al. Molecular diagnosis of Burkitt's lymphoma. N Engl J Med 2006; 354: 2431\u20132442.","journal-title":"N Engl J Med"},{"key":"BFbcj20121_CR5","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/nature03702","volume":"435","author":"J Lu","year":"2005","unstructured":"Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D et al. MicroRNA expression profiles classify human cancers. Nature 2005; 435: 834\u2013838.","journal-title":"Nature"},{"key":"BFbcj20121_CR6","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.cell.2005.01.014","volume":"120","author":"SM Johnson","year":"2005","unstructured":"Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A et al. RAS is regulated by the let-7 microRNA family. Cell 2005; 120: 635\u2013647.","journal-title":"Cell"},{"key":"BFbcj20121_CR7","doi-asserted-by":"publisher","first-page":"15524","DOI":"10.1073\/pnas.242606799","volume":"99","author":"GA Calin","year":"2002","unstructured":"Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2002; 99: 15524\u201315529.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFbcj20121_CR8","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.cell.2007.07.021","volume":"131","author":"C Xiao","year":"2007","unstructured":"Xiao C, Calado DP, Galler G, Thai TH, Patterson HC, Wang J et al. MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell 2007; 131: 146\u2013159.","journal-title":"Cell"},{"key":"BFbcj20121_CR9","doi-asserted-by":"publisher","first-page":"19971","DOI":"10.1073\/pnas.0709313104","volume":"104","author":"S Mi","year":"2007","unstructured":"Mi S, Lu J, Sun M, Li Z, Zhang H, Neilly MB et al. MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia. Proc Natl Acad Sci USA 2007; 104: 19971\u201319976.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFbcj20121_CR10","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1038\/sj.leu.2404853","volume":"21","author":"E Ruiz-Ballesteros","year":"2007","unstructured":"Ruiz-Ballesteros E, Mollejo M, Mateo M, Algara P, Martinez P, Piris MA . MicroRNA losses in the frequently deleted region of 7q in SMZL. Leukemia 2007; 21: 2547\u20132549.","journal-title":"Leukemia"},{"key":"BFbcj20121_CR11","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1111\/j.1365-2141.2008.07237.x","volume":"142","author":"A Roehle","year":"2008","unstructured":"Roehle A, Hoefig KP, Repsilber D, Thorns C, Ziepert M, Wesche KO et al. MicroRNA signatures characterize diffuse large B-cell lymphomas and follicular lymphomas. Br J Haematol 2008; 142: 732\u2013744.","journal-title":"Br J Haematol"},{"key":"BFbcj20121_CR12","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1002\/ijc.22800","volume":"121","author":"CH Lawrie","year":"2007","unstructured":"Lawrie CH, Soneji S, Marafioti T, Cooper CD, Palazzo S, Paterson JC et al. MicroRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma. Int J Cancer 2007; 121: 1156\u20131161.","journal-title":"Int J Cancer"},{"key":"BFbcj20121_CR13","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1182\/blood-2010-11-321554","volume":"118","author":"S Montes-Moreno","year":"2011","unstructured":"Montes-Moreno S, Martinez N, Sanchez-Espiridion B, Diaz Uriarte R, Rodriguez ME, Saez A et al. miRNA expression in diffuse large B-cell lymphoma treated with chemoimmunotherapy. Blood 2011; 118: 1034\u20131040.","journal-title":"Blood"},{"key":"BFbcj20121_CR14","doi-asserted-by":"publisher","first-page":"9991","DOI":"10.1073\/pnas.1732008100","volume":"100","author":"G Wright","year":"2003","unstructured":"Wright G, Tan B, Rosenwald A, Hurt EH, Wiestner A, Staudt LM . A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma. Proc Natl Acad Sci USA 2003; 100: 9991\u20139996.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFbcj20121_CR15","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0002-9440(10)63284-1","volume":"165","author":"J Iqbal","year":"2004","unstructured":"Iqbal J, Sanger WG, Horsman DE, Rosenwald A, Pickering DL, Dave B et al. BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma. Am J Pathol 2004; 165: 159\u2013166.","journal-title":"Am J Pathol"},{"key":"BFbcj20121_CR16","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","volume":"103","author":"CP Hans","year":"2004","unstructured":"Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, Ott G et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 2004; 103: 275\u2013282.","journal-title":"Blood"},{"key":"BFbcj20121_CR17","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1038\/leu.2010.91","volume":"24","author":"L Di Lisio","year":"2010","unstructured":"Di Lisio L, Gomez-Lopez G, Sanchez-Beato M, Gomez-Abad C, Rodriguez ME, Villuendas R et al. Mantle cell lymphoma: transcriptional regulation by microRNAs. Leukemia 2010; 24: 1335\u20131342.","journal-title":"Leukemia"},{"key":"BFbcj20121_CR18","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/modpathol.2008.148","volume":"22","author":"M Aggarwal","year":"2009","unstructured":"Aggarwal M, Villuendas R, Gomez G, Rodriguez-Pinilla SM, Sanchez-Beato M, Alvarez D et al. TCL1A expression delineates biological and clinical variability in B-cell lymphoma. Mod Pathol 2009; 22: 206\u2013215.","journal-title":"Mod Pathol"},{"key":"BFbcj20121_CR19","doi-asserted-by":"publisher","first-page":"843","DOI":"10.4161\/cc.8.6.7907","volume":"8","author":"ME Peter","year":"2009","unstructured":"Peter ME . Let-7 and miR-200 microRNAs: guardians against pluripotency and cancer progression. Cell Cycle 2009; 8: 843\u2013852.","journal-title":"Cell Cycle"},{"key":"BFbcj20121_CR20","doi-asserted-by":"publisher","first-page":"9762","DOI":"10.1158\/0008-5472.CAN-07-2462","volume":"67","author":"VB Sampson","year":"2007","unstructured":"Sampson VB, Rong NH, Han J, Yang Q, Aris V, Soteropoulos P et al. MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells. Cancer Res 2007; 67: 9762\u20139770.","journal-title":"Cancer Res"},{"key":"BFbcj20121_CR21","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/nature07823","volume":"458","author":"P Gao","year":"2009","unstructured":"Gao P, Tchernyshyov I, Chang TC, Lee YS, Kita K, Ochi T et al. c-Myc suppression of miR-23a\/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature 2009; 458: 762\u2013765.","journal-title":"Nature"},{"key":"BFbcj20121_CR22","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/cdd.2009.58","volume":"17","author":"AH Lund","year":"2010","unstructured":"Lund AH . miR-10 in development and cancer. Cell Death Differ 2010; 17: 209\u2013214.","journal-title":"Cell Death Differ"},{"key":"BFbcj20121_CR23","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/path.1825","volume":"207","author":"J Kluiver","year":"2005","unstructured":"Kluiver J, Poppema S, De Jong D, Blokzijl T, Harms G, Jacobs S et al. BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas. J Pathol 2005; 207: 243\u2013249.","journal-title":"J Pathol"},{"key":"BFbcj20121_CR24","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1111\/j.1365-2141.2010.08111.x","volume":"149","author":"JL Robertus","year":"2010","unstructured":"Robertus JL, Kluiver J, Weggemans C, Harms G, Reijmers RM, Swart Y et al. MiRNA profiling in B non-Hodgkin lymphoma: a MYC-related miRNA profile characterizes Burkitt lymphoma. Br J Haematol 2010; 149: 896\u2013899.","journal-title":"Br J Haematol"},{"key":"BFbcj20121_CR25","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/nsmb.1533","volume":"16","author":"SY Park","year":"2009","unstructured":"Park SY, Lee JH, Ha M, Nam JW, Kim VN . miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42. Nat Struct Mol Biol 2009; 16: 23\u201329.","journal-title":"Nat Struct Mol Biol"},{"key":"BFbcj20121_CR26","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1158\/1541-7786.MCR-08-0507","volume":"7","author":"L Du","year":"2009","unstructured":"Du L, Schageman JJ, Subauste MC, Saber B, Hammond SM, Prudkin L et al. miR-93, miR-98, and miR-197 regulate expression of tumor suppressor gene FUS1. Mol Cancer Res 2009; 7: 1234\u20131243.","journal-title":"Mol Cancer Res"},{"key":"BFbcj20121_CR27","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.1158\/0008-5472.CAN-09-4456","volume":"70","author":"A Veronese","year":"2010","unstructured":"Veronese A, Lupini L, Consiglio J, Visone R, Ferracin M, Fornari F et al. Oncogenic role of miR-483-3p at the IGF2\/483 locus. Cancer Res 2010; 70: 3140\u20133149.","journal-title":"Cancer Res"},{"key":"BFbcj20121_CR28","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/cncr.24991","volume":"116","author":"C Gao","year":"2010","unstructured":"Gao C, Zhang Z, Liu W, Xiao S, Gu W, Lu H . Reduced microRNA-218 expression is associated with high nuclear factor kappa B activation in gastric cancer. Cancer 2010; 116: 41\u201349.","journal-title":"Cancer"},{"key":"BFbcj20121_CR29","doi-asserted-by":"publisher","first-page":"e118","DOI":"10.1182\/blood-2010-05-285403","volume":"116","author":"DD Jima","year":"2010","unstructured":"Jima DD, Zhang J, Jacobs C, Richards KL, Dunphy CH, Choi WW et al. Deep sequencing of the small RNA transcriptome of normal and malignant human B cells identifies hundreds of novel microRNAs. Blood 2010; 116: e118\u2013e127.","journal-title":"Blood"},{"key":"BFbcj20121_CR30","doi-asserted-by":"publisher","first-page":"5537","DOI":"10.1111\/j.1742-4658.2009.07237.x","volume":"276","author":"LM Guo","year":"2009","unstructured":"Guo LM, Pu Y, Han Z, Liu T, Li YX, Liu M et al. MicroRNA-9 inhibits ovarian cancer cell growth through regulation of NF-kappaB1. FEBS J 2009; 276: 5537\u20135546.","journal-title":"FEBS J"},{"key":"BFbcj20121_CR31","doi-asserted-by":"publisher","first-page":"242","DOI":"10.2353\/ajpath.2008.080009","volume":"173","author":"K Nie","year":"2008","unstructured":"Nie K, Gomez M, Landgraf P, Garcia JF, Liu Y, Tan LH et al. MicroRNA-mediated down-regulation of PRDM1\/Blimp-1 in Hodgkin\/Reed\u2013Sternberg cells: a potential pathogenetic lesion in Hodgkin lymphomas. Am J Pathol 2008; 173: 242\u2013252.","journal-title":"Am J Pathol"},{"key":"BFbcj20121_CR32","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1101\/gad.1640608","volume":"22","author":"SM Park","year":"2008","unstructured":"Park SM, Gaur AB, Lengyel E, Peter ME . The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev 2008; 22: 894\u2013907.","journal-title":"Genes Dev"},{"key":"BFbcj20121_CR33","doi-asserted-by":"publisher","first-page":"15535","DOI":"10.1073\/pnas.0808266105","volume":"105","author":"Z Li","year":"2008","unstructured":"Li Z, Lu J, Sun M, Mi S, Zhang H, Luo RT et al. Distinct microRNA expression profiles in acute myeloid leukemia with common translocations. Proc Natl Acad Sci USA 2008; 105: 15535\u201315540.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFbcj20121_CR34","first-page":"1069","volume":"34","author":"K Motoyama","year":"2009","unstructured":"Motoyama K, Inoue H, Takatsuno Y, Tanaka F, Mimori K, Uetake H et al. Over- and under-expressed microRNAs in human colorectal cancer. Int J Oncol 2009; 34: 1069\u20131075.","journal-title":"Int J Oncol"},{"key":"BFbcj20121_CR35","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/path.2610","volume":"220","author":"F Haller","year":"2010","unstructured":"Haller F, Von Heydebreck A, Zhang JD, Gunawan B, Langer C, Ramadori G et al. Localization- and mutation-dependent microRNA (miRNA) expression signatures in gastrointestinal stromal tumours (GISTs), with a cluster of co-expressed miRNAs located at 14q32.31. J Pathol 2010; 220: 71\u201386.","journal-title":"J Pathol"},{"key":"BFbcj20121_CR36","doi-asserted-by":"publisher","first-page":"e2141","DOI":"10.1371\/journal.pone.0002141","volume":"3","author":"A Dixon-Mciver","year":"2008","unstructured":"Dixon-Mciver A, East P, Mein CA, Cazier JB, Molloy G, Chaplin T et al. Distinctive patterns of microRNA expression associated with karyotype in acute myeloid leukaemia. PLoS One 2008; 3: e2141.","journal-title":"PLoS One"},{"key":"BFbcj20121_CR37","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1084\/jem.20100458","volume":"207","author":"KD Rasmussen","year":"2010","unstructured":"Rasmussen KD, Simmini S, Abreu-Goodger C, Bartonicek N, Di Giacomo M, Bilbao-Cortes D et al. The miR-144\/451 locus is required for erythroid homeostasis. J Exp Med 2010; 207: 1351\u20131358.","journal-title":"J Exp Med"},{"key":"BFbcj20121_CR38","doi-asserted-by":"publisher","first-page":"11590","DOI":"10.1158\/0008-5472.CAN-06-3613","volume":"66","author":"Y Pekarsky","year":"2006","unstructured":"Pekarsky Y, Santanam U, Cimmino A, Palamarchuk A, Efanov A, Maximov V et al. Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181. Cancer Res 2006; 66: 11590\u201311593.","journal-title":"Cancer Res"},{"key":"BFbcj20121_CR39","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1056\/NEJMe068075","volume":"354","author":"NL Harris","year":"2006","unstructured":"Harris NL, Horning SJ . Burkitt's lymphoma\u2014the message from microarrays. N Engl J Med 2006; 354: 2495\u20132498.","journal-title":"N Engl J Med"},{"key":"BFbcj20121_CR40","doi-asserted-by":"publisher","first-page":"6133","DOI":"10.1038\/sj.onc.1210436","volume":"26","author":"JL Mott","year":"2007","unstructured":"Mott JL, Kobayashi S, Bronk SF, Gores GJ . Mir-29 regulates Mcl-1 protein expression and apoptosis. Oncogene 2007; 26: 6133\u20136140.","journal-title":"Oncogene"},{"key":"BFbcj20121_CR41","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/j.1365-3083.2010.02383.x","volume":"71","author":"L Li","year":"2010","unstructured":"Li L, Chen XP, Li YJ . MicroRNA-146a and human disease. Scand J Immunol 2010; 71: 227\u2013231.","journal-title":"Scand J Immunol"},{"key":"BFbcj20121_CR42","doi-asserted-by":"publisher","first-page":"e6816","DOI":"10.1371\/journal.pone.0006816","volume":"4","author":"Q Ji","year":"2009","unstructured":"Ji Q, Hao X, Zhang M, Tang W, Yang M, Li L et al. MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells. PLoS One 2009; 4: e6816.","journal-title":"PLoS One"},{"key":"BFbcj20121_CR43","doi-asserted-by":"publisher","first-page":"7345","DOI":"10.1158\/0008-5472.CAN-11-1874","volume":"71","author":"P O\u2019brien","year":"2011","unstructured":"O\u2019brien P, Morin Jr P, Ouellette RJ, Robichaud GA . The Pax-5 gene: a pluripotent regulator of B-cell differentiation and cancer disease. Cancer Res 2011; 71: 7345\u20137350.","journal-title":"Cancer Res"},{"key":"BFbcj20121_CR44","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1084\/jem.20090765","volume":"206","author":"BA Malynn","year":"2009","unstructured":"Malynn BA, Ma A . A20 takes on tumors: tumor suppression by an ubiquitin-editing enzyme. J Exp Med 2009; 206: 977\u2013980.","journal-title":"J Exp Med"},{"key":"BFbcj20121_CR45","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.2353\/ajpath.2010.091291","volume":"177","author":"K Nie","year":"2010","unstructured":"Nie K, Zhang T, Allawi H, Gomez M, Liu Y, Chadburn A et al. Epigenetic down-regulation of the tumor suppressor gene PRDM1\/Blimp-1 in diffuse large B cell lymphomas: a potential role of the microRNA let-7. Am J Pathol 2010; 177: 1470\u20131479.","journal-title":"Am J Pathol"},{"key":"BFbcj20121_CR46","doi-asserted-by":"publisher","first-page":"4586","DOI":"10.1182\/blood-2008-09-178186","volume":"113","author":"J Zhang","year":"2009","unstructured":"Zhang J, Jima DD, Jacobs C, Fischer R, Gottwein E, Huang G et al. Patterns of microRNA expression characterize stages of human B-cell differentiation. Blood 2009; 113: 4586\u20134594.","journal-title":"Blood"},{"key":"BFbcj20121_CR47","doi-asserted-by":"publisher","first-page":"3754","DOI":"10.1182\/blood-2008-10-184077","volume":"113","author":"R Malumbres","year":"2009","unstructured":"Malumbres R, Sarosiek KA, Cubedo E, Ruiz JW, Jiang X, Gascoyne RD et al. Differentiation stage-specific expression of microRNAs in B lymphocytes and diffuse large B-cell lymphomas. Blood 2009; 113: 3754\u20133764.","journal-title":"Blood"},{"key":"BFbcj20121_CR48","first-page":"467","volume":"91","author":"JF Garcia","year":"2006","unstructured":"Garcia JF, Roncador G, Sanz AI, Maestre L, Lucas E, Montes-Moreno S et al. PRDM1\/BLIMP-1 expression in multiple B and T-cell lymphoma. Haematologica 2006; 91: 467\u2013474.","journal-title":"Haematologica"},{"key":"BFbcj20121_CR49","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.immuni.2007.10.009","volume":"27","author":"E Vigorito","year":"2007","unstructured":"Vigorito E, Perks KL, Abreu-Goodger C, Bunting S, Xiang Z, Kohlhaas S et al. MicroRNA-155 regulates the generation of immunoglobulin class-switched plasma cells. Immunity 2007; 27: 847\u2013859.","journal-title":"Immunity"},{"key":"BFbcj20121_CR50","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.ccr.2006.04.020","volume":"9","author":"Y Saito","year":"2006","unstructured":"Saito Y, Liang G, Egger G, Friedman JM, Chuang JC, Coetzee GA et al. Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell 2006; 9: 435\u2013443.","journal-title":"Cancer Cell"},{"key":"BFbcj20121_CR51","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.4049\/jimmunol.173.2.1158","volume":"173","author":"C Tunyaplin","year":"2004","unstructured":"Tunyaplin C, Shaffer AL, Angelin-Duclos CD, Yu X, Staudt LM, Calame KL . Direct repression of prdm1 by Bcl-6 inhibits plasmacytic differentiation. J Immunol 2004; 173: 1158\u20131165.","journal-title":"J Immunol"},{"key":"BFbcj20121_CR52","doi-asserted-by":"publisher","first-page":"23204","DOI":"10.1074\/jbc.M109.031427","volume":"284","author":"IK Guttilla","year":"2009","unstructured":"Guttilla IK, White BA . Coordinate regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast cancer cells. J Biol Chem 2009; 284: 23204\u201323216.","journal-title":"J Biol Chem"},{"key":"BFbcj20121_CR53","doi-asserted-by":"publisher","first-page":"6069","DOI":"10.1182\/blood-2009-01-199679","volume":"113","author":"K Dunleavy","year":"2009","unstructured":"Dunleavy K, Pittaluga S, Czuczman MS, Dave SS, Wright G, Grant N et al. Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma. Blood 2009; 113: 6069\u20136076.","journal-title":"Blood"},{"key":"BFbcj20121_CR54","doi-asserted-by":"publisher","first-page":"670","DOI":"10.3324\/haematol.12221","volume":"93","author":"BI Ferreira","year":"2008","unstructured":"Ferreira BI, Garcia JF, Suela J, Mollejo M, Camacho FI, Carro A et al. Comparative genome profiling across subtypes of low-grade B-cell lymphoma identifies type-specific and common aberrations that target genes with a role in B-cell neoplasia. Haematologica 2008; 93: 670\u2013679.","journal-title":"Haematologica"},{"key":"BFbcj20121_CR55","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1002\/path.2410","volume":"216","author":"E Leucci","year":"2008","unstructured":"Leucci E, Cocco M, Onnis A, De Falco G, Van Cleef P, Bellan C et al. MYC translocation-negative classical Burkitt lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulation. J Pathol 2008; 216: 440\u2013450.","journal-title":"J Pathol"},{"key":"BFbcj20121_CR56","doi-asserted-by":"publisher","first-page":"6681","DOI":"10.1182\/blood-2009-01-202028","volume":"113","author":"C Li","year":"2009","unstructured":"Li C, Kim SW, Rai D, Bolla AR, Adhvaryu S, Kinney MC et al. Copy number abnormalities, MYC activity, and the genetic fingerprint of normal B cells mechanistically define the microRNA profile of diffuse large B-cell lymphoma. Blood 2009; 113: 6681\u20136690.","journal-title":"Blood"},{"key":"BFbcj20121_CR57","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/ng.2007.30","volume":"40","author":"TC Chang","year":"2008","unstructured":"Chang TC, Yu D, Lee YS, Wentzel EA, Arking DE, West KM et al. Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet 2008; 40: 43\u201350.","journal-title":"Nat Genet"},{"key":"BFbcj20121_CR58","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1038\/leu.2011.156","volume":"25","author":"D Lenze","year":"2011","unstructured":"Lenze D, Leoncini L, Hummel M, Volinia S, Liu CG, Amato T et al. The different epidemiologic subtypes of Burkitt lymphoma share a homogenous micro RNA profile distinct from diffuse large B-cell lymphoma. Leukemia 2011; 25: 1869\u20131876.","journal-title":"Leukemia"},{"key":"BFbcj20121_CR59","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.immuni.2010.05.009","volume":"32","author":"S Kuchen","year":"2010","unstructured":"Kuchen S, Resch W, Yamane A, Kuo N, Li Z, Chakraborty T et al. Regulation of microRNA expression and abundance during lymphopoiesis. Immunity 2010; 32: 828\u2013839.","journal-title":"Immunity"}],"container-title":["Blood Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/bcj20121.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bcj20121","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bcj20121.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T22:42:16Z","timestamp":1672958536000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bcj20121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,17]]},"references-count":59,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2012,2]]}},"alternative-id":["BFbcj20121"],"URL":"https:\/\/doi.org\/10.1038\/bcj.2012.1","relation":{},"ISSN":["2044-5385"],"issn-type":[{"value":"2044-5385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,17]]},"assertion":[{"value":"21 October 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2012","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2012","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2012","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}